1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
202.31%
Revenue growth above 1.5x 6203.T's 39.28%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
157.37%
Gross profit growth above 1.5x 6203.T's 35.21%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
9397.65%
EBIT growth above 1.5x 6203.T's 1147.06%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
6731.65%
Operating income growth above 1.5x 6203.T's 430.91%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
2551.92%
Net income growth 1.25-1.5x 6203.T's 1970.59%. Bruce Berkowitz would see if strategic cost cutting or product mix explains this difference.
2619.15%
EPS growth 1.25-1.5x 6203.T's 1967.65%. Bruce Berkowitz would check if strategic initiatives like cost cutting or better capital management explain the difference.
2619.15%
Diluted EPS growth 1.25-1.5x 6203.T's 1967.65%. Bruce Berkowitz would verify if strategic moves (e.g., targeted acquisitions, cost cuts) explain the edge.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-76.37%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
232.45%
Positive 5Y CAGR while 6203.T is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
157.40%
3Y revenue/share CAGR above 1.5x 6203.T's 1.50%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
-100.00%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
111.29%
Below 50% of 6203.T's 314.96%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
548.37%
Positive 5Y CAGR while 6203.T is negative. John Neff might view this as a strong mid-term relative advantage.
159.94%
3Y net income/share CAGR 1.25-1.5x 6203.T's 131.60%. Bruce Berkowitz might see new markets, M&A, or better cost discipline driving the difference.
-55.85%
Negative equity/share CAGR over 10 years while 6203.T stands at 15.21%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
60.52%
Positive 5Y equity/share CAGR while 6203.T is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
36.36%
Positive short-term equity growth while 6203.T is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
34.79%
AR growth well above 6203.T's 37.55%. Michael Burry fears inflated revenue or higher default risk in the near future.
-46.20%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-18.86%
Negative asset growth while 6203.T invests at 0.34%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
11.64%
Positive BV/share change while 6203.T is negative. John Neff sees a clear edge over a competitor losing equity.
-36.17%
We’re deleveraging while 6203.T stands at 15.65%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
298.15%
R&D growth of 298.15% while 6203.T is zero. Bruce Berkowitz checks if the moderate investment leads to meaningful product differentiation.
15.55%
SG&A growth well above 6203.T's 0.27%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.